Van Ophoven

Revision as of 19:58, 7 January 2012 by Gordoben (talk | contribs) (Imported from Wikispaces)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Hyperbaric oxygen therapy reduced pain associated with interstitial cystitis

Clinical bottom line:
1. Mean pain score reduced following HBOT2. Trend toward benefit from HBOT for urgency, frequency, bladder volume and subjective response, but no statistically significant differences

Citation/s:1. van Ophoven A, Rossbach G, Pajonk F, Hertle L. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis a randomised, sham controlled, double blind trial. Journal of Urology 2006; 176:1442-1446. Lead author's name and fax: [| avo@uni-muenster.de]

Three-part Clinical Question: For patients with interstitial cystitis, does the application of hyperbaric oxygen result in any improvement in symptoms? Search Terms: Cysitis, interstitial, pelvic pain

The Study:Double-blinded randomised controlled trial with intention-to-treat. The Study Patients: Adult women with a diagnosis of interstitial cystitis. Control group (N = 7; 7 analysed): Baseline therapy for each individual was continued plus air breathing at 1.3 to 1.4 ATA for 90 minutes daily to 30 sessions over 5 weeks. Experimental group (N = 14; 14 analysed): As above but 100% oxygen breathing at 2.4 ATA.

The Evidence:

Outcome Time to Outcome Sham rate HBO rate Relative risk reduction Absolute risk reduction NNT
Symptomatic responders 3 months 0 0.21 INF 0.21 5
^ 95% Confidence Intervals: -0.001 to 0.43 NNT 2 to INFNNH 1,194 to INF
Measure Sham Group HBO Group Difference 95% CI
^ Mean SD Mean SD ^ ^
Interstitial cystitis index at 3 months 26.7 5.8 19.9 7.9 6.8 -0.28 to 13.88
Pain score (VAS) 3 months (0-100) 55.7 27.8 31.2 19.8 24.5 2.57 to 46.43
Bladder volume 3 months (mls) 118 36 147 49 29 -14.60 to 72.60

Comments: 1. The difference in the proportion of symptomatic responders on a subjective scale (3 HBO versus 0 sham) is reported in the paper as statistically significant (P<0.05), but our calculations do not support this finding (P=0.55 by Fisher's exact test, double one-sided P method). {Authors agree with the published figure is incorrect.} 2. Underpowered study with no sample size calculation.

Appraised by: Sean Hopson and Mike Bennett, Sydney; Friday, 10 November 2006Email: [| m.bennett@unsw.edu.au] Kill or Update By: March 2007

BACK